Including More People of Color in Heart Failure Research

Ad Blocker Detected

Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker.

Photo Credit: Rapeepong Puttakumwong / Getty Images

SOURCES:

American College of Cardiology: “Latest Evidence on Racial Inequities and Biases in Advanced Heart Failure.”

American Journal of Preventive Cardiology: “Improving the enrollment of women and racially/ethnically diverse populations in cardiovascular clinical trials: An ASPC practice statement.”

CDC: “The Syphilis Study at Tuskegee Timeline.”

Circulation: Heart Failure: “Factors Associated with Racial and Ethnic Diversity Among Heart Failure Trial Participants: A Systematic Bibliometric Review.”

Clyde Yancy, MD, vice dean of Diversity & Inclusion; chief of the Division of Cardiology, Northwestern University, Feinberg School of Medicine.

FDA: “FDA Takes Important Steps to Increase Racial and Ethnic Diversity in Clinical Trials.”

JAMA Cardiology: “Enrollment of Older Patients, Women, and Racial and Ethnic Minorities in Contemporary Heart Failure Clinical Trials,” “Improving Enrollment of Underrepresented Racial and Ethnic Populations in Heart Failure Trials: A Call to Action from the Heart Failure Collaboratory.”

Journal of the American Heart Association: “Recruitment of Black Adults into Cardiovascular Disease Trials.”

Martin Mendoza, PhD, director of health equity, All of Us research program, National Institutes of Health.

Patrice Desvigne-Nickens, MD, medical officer, Division of Cardiovascular Science’s Heart Failure and Arrhythmias Branch, National Heart, Lung, and Blood Institute.

National Institutes of Health: “NIH Policy and Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research.”

Source: https://www.webmd.com/heart-disease/heart-failure/features/need-more-minorities-clinical-trials?src=RSS_PUBLIC